These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35836691)

  • 21. Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial.
    Harreiter J; Just I; Leutner M; Bastian M; Brath H; Schelkshorn C; Klepochova R; Krššák M; Kautzky-Willer A
    Diabetes Obes Metab; 2021 May; 23(5):1129-1139. PubMed ID: 33464703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial.
    Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
    BMC Med; 2021 Aug; 19(1):183. PubMed ID: 34407811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.
    Halpern A; Mancini MC; Suplicy H; Zanella MT; Repetto G; Gross J; Jadzinsky M; Barranco J; Aschner P; Ramirez L; Matos AG
    Diabetes Obes Metab; 2003 May; 5(3):180-8. PubMed ID: 12681025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous associations of insoluble dietary fibre intake with subsequent glycosylated Hb levels among Chinese adults with type 2 diabetes: a quantile regression approach.
    Tan Z; Ruan X; Chen Y; Jiang J; Zhou Y; Qiu H; Qin G; Xu WH
    Br J Nutr; 2014 Sep; 112(6):958-63. PubMed ID: 25006833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between glycaemic control and lipid profile in type 2 diabetes mellitus patients in a low-resource setting.
    Nnakenyi ID; Nnakenyi EF; Parker EJ; Uchendu NO; Anaduaka EG; Ezeanyika LU
    Pan Afr Med J; 2022; 41():281. PubMed ID: 35855025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study.
    Sargeant LA; Khaw KT; Bingham S; Day NE; Luben RN; Oakes S; Welch A; Wareham NJ
    Eur J Clin Nutr; 2001 May; 55(5):342-8. PubMed ID: 11378807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary intakes by levels of glycemic control for black and white adults with non-insulin dependent diabetes mellitus (NIDDM).
    Bell RA; Summerson JH; Konen JC
    J Am Coll Nutr; 1995 Apr; 14(2):144-51. PubMed ID: 7790688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of random plasma glucose for assessment of glycaemic control in type 2 diabetes mellitus.
    Ain Q; Latif A; Jaffar SR; Ijaz A
    J Pak Med Assoc; 2017 Sep; 67(9):1353-1356. PubMed ID: 28924273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.
    Battelino T; Bergenstal RM; Rodríguez A; Fernández Landó L; Bray R; Tong Z; Brown K
    Lancet Diabetes Endocrinol; 2022 Jun; 10(6):407-417. PubMed ID: 35468321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. EURODIAB IDDM Complications Study Group.
    Buyken AE; Toeller M; Heitkamp G; Irsigler K; Holler C; Santeusanio F; Stehle P; Fuller JH
    Diabet Med; 2000 May; 17(5):351-9. PubMed ID: 10872533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
    Fontvieille AM; Rizkalla SW; Penfornis A; Acosta M; Bornet FR; Slama G
    Diabet Med; 1992 Jun; 9(5):444-50. PubMed ID: 1611832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of glycaemic control among type 2 diabetes mellitus patients in Northern State of Kedah, Malaysia: a cross-sectional analysis of 5 years national diabetes registry 2014-2018.
    Hassan MR; Jamhari MN; Hayati F; Ahmad N; Zamzuri MIA; Nawi AM; Sharif KY; Sufri M; Ahmad SB; Ismail N; Rahim SSSA; Jeffree MS
    Pan Afr Med J; 2021; 39():206. PubMed ID: 34603587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes.
    Ewers B; Bruun JM; Vilsbøll T
    BMJ Open; 2019 Nov; 9(11):e032893. PubMed ID: 31753900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low glycaemic index diets improve glucose tolerance and body weight in women with previous history of gestational diabetes: a six months randomized trial.
    Shyam S; Arshad F; Abdul Ghani R; Wahab NA; Safii NS; Nisak MY; Chinna K; Kamaruddin NA
    Nutr J; 2013 May; 12():68. PubMed ID: 23705645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.